Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/125575
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRello Varona, Santiago-
dc.contributor.authorHerrero Martín, David-
dc.contributor.authorLagares Tena, Laura-
dc.contributor.authorLópez Alemany, Roser-
dc.contributor.authorMulet Margalef, Núria-
dc.contributor.authorHuertas-Martínez, Juan-
dc.contributor.authorGarcia Monclús, Silvia-
dc.contributor.authorGarcía del Muro Solans, Xavier-
dc.contributor.authorMuñoz Pinedo, Cristina-
dc.contributor.authorMartínez Tirado, Òscar-
dc.date.accessioned2018-10-24T10:48:41Z-
dc.date.available2018-10-24T10:48:41Z-
dc.date.issued2015-04-07-
dc.identifier.issn2234-943X-
dc.identifier.urihttp://hdl.handle.net/2445/125575-
dc.description.abstractCell death can occur through different mechanisms, defined by their nature and physiological implications. Correct assessment of cell death is crucial for cancer therapy success. Sarcomas are a large and diverse group of neoplasias from mesenchymal origin. Among cell death types, apoptosis is by far the most studied in sarcomas. Albeit very promising in other fields, regulated necrosis and other cell death circumstances (as so-called "autophagic cell death" or "mitotic catastrophe") have not been yet properly addressed in sarcomas. Cell death is usually quantified in sarcomas by unspecific assays and in most cases the precise sequence of events remains poorly characterized. In this review, our main objective is to put into context the most recent sarcoma cell death findings in the more general landscape of different cell death modalities.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherFrontiers Media-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3389/fonc.2015.00082-
dc.relation.ispartofFrontiers in Oncology, 2015, num. 5, p. 82-
dc.relation.urihttps://doi.org/10.3389/fonc.2015.00082-
dc.rightscc-by (c) Rello Varona, Santiago et al., 2015-
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es-
dc.sourceArticles publicats en revistes (Ciències Clíniques)-
dc.subject.classificationNecrosi-
dc.subject.classificationMort cel·lular-
dc.subject.classificationApoptosi-
dc.subject.otherNecrosis-
dc.subject.otherCell death-
dc.subject.otherApoptosis-
dc.titleThe importance of being dead: cell death mechanisms assessment in anti-sarcoma therapy-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec679992-
dc.date.updated2018-10-24T10:48:46Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.pmid25905041-
Appears in Collections:Articles publicats en revistes (Ciències Clíniques)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
679992.pdf980.91 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons